FAG
ALXO icon

Financial Advisory Group’s ALX Oncology ALXO Stock Holding History

Financial Advisory Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$350K Hold
31,417
– – 0.06% 72
2023
Q4 		$468K Hold
31,417
– – 0.09% 62
2023
Q3 		$151K Hold
31,417
– – 0.03% 81
2023
Q2 		$236K Hold
31,417
– – 0.05% 76
2023
Q1 		$142K Hold
31,417
– – 0.03% 87
2022
Q4 		$354K Hold
31,417
– – 0.08% 66
2022
Q3 		$301K Hold
31,417
– – 0.07% 70
2022
Q2 		$254K Hold
31,417
– – 0.05% 76
2022
Q1 		$531K Hold
31,417
– – 0.1% 54
2021
Q4 		$675K Hold
31,417
– – 0.13% 50
2021
Q3 		$2.32M Sell
31,417
-22,624
-42% -$1.51M 0.51% 24
2021
Q2 		$2.96M Buy
+54,041
New +$3.23M 0.71% 18

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Financial Advisory Group's ALXO Position: Q1 2024 in Review

Financial Advisory Group held its ALX Oncology (ALXO) position steady in Q1 2024 at 31,417 shares worth $350K. The position accounts for 0.06% of the portfolio, ranked #72.

Financial Advisory Group first reported a position in ALXO in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.96M in Q2 2021. 106 funds tracked by Wall St. Rank hold ALXO as of Q1 2024.

  • Financial Advisory Group held 31,417 shares of ALX Oncology worth $350K as of Q1 2024.
  • Financial Advisory Group left its ALX Oncology share count unchanged in Q1 2024.
  • ALX Oncology made up 0.06% of Financial Advisory Group's portfolio in Q1 2024, its #72 holding.
  • Financial Advisory Group first reported a position in ALX Oncology in Q2 2021 and has held it in 12 quarters since.
  • Financial Advisory Group's ALX Oncology position peaked at $2.96M in Q2 2021.
  • 106 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2024.

Based on Financial Advisory Group's 13F filing for Q1 2024, filed 10 May 2024.